Comparison
Decapeptide-12 vs Matrixyl
Both are cosmetic & topical, so the meaningful differences are in kinetics, evidence and regulatory status.
| Decapeptide-12 | Matrixyl | |
|---|---|---|
| Class | Cosmetic & topical | Cosmetic & topical |
| Evidence | Clinical trials | Clinical trials |
| Human trials | ~5 | ~10 |
| Half-life | Topical | Topical |
| Reported range | 1 mg | 3-8 mg |
| Frequency | Applied topically 2x daily at approximately 0.01-0.1% | Applied topically 1-2x daily at 3-8% concentration |
| Routes | Topical | Topical |
| FDA approved | No | No |
| Research use only | No | No |
| Banned in sport | No | No |
| Studied for | Melasma, Hyperpigmentation, Skin brightening | Collagen stimulation, Wrinkle reduction, Skin firmness |
| Reported side effects | Mild irritation, Transient dryness | Mild local irritation |
Decapeptide-12
Decapeptide-12 competitively inhibits tyrosinase, the rate-limiting enzyme converting tyrosine to melanin. Unlike hydroquinone, which is cytotoxic to melanocytes, it suppresses pigment production without destroying the cells, so it does not carry the ochronosis risk associated with prolonged hydroquinone use. Onset is correspondingly slower, typically requiring eight to sixteen weeks for visible change.
Matrixyl
Matrixyl is the pentapeptide KTTKS, a subfragment of type I procollagen, conjugated to palmitic acid to allow it to cross the lipid barrier of the stratum corneum. The fragment acts as a feedback signal that collagen has been degraded, prompting fibroblasts to increase synthesis of collagen I, collagen III and fibronectin. Controlled split-face human studies have shown measurable improvement in wrinkle depth, which puts it ahead of most of the cosmetic peptide category on evidence. It is not the same as Matrixyl 3000, a different blend of palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7.
Decapeptide-12 vs Matrixyl: common questions
What is the difference between Decapeptide-12 and Matrixyl?
Both are cosmetic & topical. Decapeptide-12: A tyrosinase-inhibiting peptide used for hyperpigmentation, positioned as a gentler alternative to hydroquinone. Matrixyl: A palmitoylated collagen fragment and one of the few cosmetic peptides with credible controlled human data.
Which has stronger evidence, Decapeptide-12 or Matrixyl?
They sit at the same evidence level: clinical trials. Decapeptide-12 has about 5 human studies and Matrixyl about 10.
Are Decapeptide-12 and Matrixyl FDA approved?
Neither is FDA approved for any indication.
References
Regulatory and primary sources
- PubChem compound record (CID 25087629) ↗ · structure, identifiers, synonyms
- CAS Registry Number 214047-00-4 ↗ · chemical identity
Published literature
- A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.J Drugs Dermatol 2009.PubMed 19663110
- Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12.J Cosmet Laser Ther 2012.PubMed 22401652 · doi:10.3109/14764172.2012.672745
- Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.J Drugs Dermatol 2013.PubMed 23839199
- Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?.Strahlenther Onkol 2004.PubMed 15127162 · doi:10.1007/s00066-004-1174-9
- Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging.J Cosmet Dermatol 2009.PubMed 19735523 · doi:10.1111/j.1473-2165.2009.00444.x
- Application of genomics to breakthroughs in the cosmetic treatment of skin ageing and discoloration.Br J Dermatol 2012.PubMed 22670614 · doi:10.1111/j.1365-2133.2012.10960.x
Literature retrieved from PubMed on October 16, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.